middle.news
Anteris finds encouraging DurAVR performance in challenging small-annulus patients
9:03am on Monday 23rd of November, 2026 AEDT
•
Healthcare
Read Story
Anteris finds encouraging DurAVR performance in challenging small-annulus patients
9:03am on Monday 23rd of November, 2026 AEDT
Key Points
1% heart failure hospitalisation at one year
8.9 mmHg mean pressure gradient and 2.2 cm² mean effective orifice area
No moderate or severe paravalvular leak or valve-related deaths reported
96% of patients in NYHA class I/II at one year
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Anteris Technologies Global (ASX:AVR)
OPEN ARTICLE